Sankalp Arora

5PUBLICATIONS
40CO-AUTHORS
Medical virologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tissue engineeringPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 02, 2025
Cytomolecular Mechanisms of Relapse and Post-Relapse Outcomes After Frontline FLT3 Inhibitor-Based Therapy in FLT3 -Mutated AML.

Sankalp Arora, Sanam Loghavi, Naval Daver

|Aug 09, 2025
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation.

Sankalp Arora, Wei-Ying Jen, Musa Yilmaz

|Apr 08, 2025
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis.

Naval Daver, Jayastu Senapati, Hagop M Kantarjian

|Jan 15, 2025
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma.

Johannes M Waldschmidt, Noori Sotudeh, Sankalp Arora

|Sep 08, 2022
Differences in Pretreatment Frailty Across Gastrointestinal Cancers in Older Adults: Results From the Cancer and Aging Resilience Evaluation Registry.

Sankalp Arora, Mackenzie E Fowler, Christian Harmon

Pageof 1

Frequent Collaborators

3 joint publications

Courtney D DiNardo

3 joint publications

Tapan M Kadia

3 joint publications

Hagop M Kantarjian

3 joint publications

Naval Daver